Acute ischemic stroke: intraarterial treatment administered within 6 hours after stroke onset was effective and safe


In patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion, intraarterial treatment is highly effective for emergency revascularization. However, proof of a beneficial effect on functional outcome is lacking.
Researchers randomly assigned eligible patients to either intraarterial treatment plus usual care or usual care alone. Eligible patients had a proximal arterial occlusion in the anterior cerebral circulation that was confirmed on vessel imaging and that could be treated intraarterially within 6 hours after symptom onset.

The primary outcome was the modified Rankin scale score at 90 days; this categorical scale measures functional outcome, with scores ranging from 0 ( no symptoms ) to 6 ( death ).

The treatment effect was estimated with ordinal logistic regression as a common odds ratio, adjusted for prespecified prognostic factors. The adjusted common odds ratio measured the likelihood that intraarterial treatment would lead to lower modified Rankin scores, as compared with usual care alone ( shift analysis ).

Researchers enrolled 500 patients at 16 medical centers in the Netherlands ( 233 assigned to intraarterial treatment and 267 to usual care alone ). The mean age was 65 years ( range, 23 to 96 ), and 445 patients ( 89.0% ) were treated with intravenous Alteplase ( Activase ) before randomization.
Retrievable stents were used in 190 of the 233 patients ( 81.5% ) assigned to intraarterial treatment.

The adjusted common odds ratio was 1.67 ( 95% confidence interval [ CI ], 1.21 to 2.30 ). There was an absolute difference of 13.5 percentage points ( 95% CI, 5.9 to 21.2 ) in the rate of functional independence ( modified Rankin score, 0 to 2 ) in favor of the intervention ( 32.6% vs. 19.1% ).

There were no significant differences in mortality or the occurrence of symptomatic intracerebral hemorrhage.

In patients with acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation, intraarterial treatment administered within 6 hours after stroke onset was effective and safe. ( Xagena )

Berkhemer OA et al, N Engl J Med 2015;372:11-20

XagenaMedicine_2015



Indietro

Altri articoli

The aim of a study was to identify whether particular subgroups of patients had an unacceptably high risk of symptomatic...


Uric acid is an antioxidant with neuroprotective effects in experimental models of stroke. Researchers have assessed whether uric acid therapy...


Few data are available from randomised trials about the effect of thrombolysis with Alteplase ( TPA; Activase, Actilyse ) on...


The SAINT I ( Stroke Acute Ischemic NXY-059 Treatment ) trial, published in the New England Journal of Medicine, has...


Patient enrolment into TROICA, a randomized, double-blind, placebo-controlled Phase III clinical study of the single-bolus thrombolytic Metalyse ( Tenecteplase )...


A Johns Hopkins study has shown that patients treated for intracerebral hemorrhage, survived more often if given 1 milligram instead...


Patient enrolment into TROICA, a randomized, double-blind, placebo-controlled Phase III clinical study of the single-bolus thrombolytic Metalyse ( Tenecteplase )...